New China Life Insurance Company Ltd
XMUN:NCL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
New China Life Insurance Company Ltd
XMUN:NCL
|
CN |
|
Daido Steel Co Ltd
F:DDL
|
JP |
|
Brii Biosciences Ltd
F:7SS
|
CN |
|
Esprit Holdings Ltd
F:ESH
|
HK |
|
Surge Copper Corp
F:G6D2
|
CA |
|
Glory Ltd
F:3O5
|
JP |
|
E
|
Esprit Holdings Ltd
XMUN:ESHB
|
HK |
|
B
|
Blue River Resources Ltd
F:0BL
|
CA |
|
Revive Therapeutics Ltd
F:31R
|
CA |
|
Esprit Holdings Ltd
F:ESHB
|
HK |
|
S
|
SDI Group PLC
F:SD0
|
UK |
|
Renold PLC
F:7M5
|
UK |
|
Oncopeptides AB
F:OND
|
SE |
Wall St Price Targets
NCL Price Targets Summary
New China Life Insurance Company Ltd
According to Wall Street analysts, the average 1-year price target for NCL is 5.05 EUR with a low forecast of 3.02 EUR and a high forecast of 6.63 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NCL's stock price target?
Price Target
5.05
EUR
According to Wall Street analysts, the average 1-year price target for NCL is 5.05 EUR with a low forecast of 3.02 EUR and a high forecast of 6.63 EUR.
What is the Revenue forecast for New China Life Insurance Company Ltd?
Projected CAGR
-9%
Over the last 13 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 3 years is -9%.
What is the Net Income forecast for New China Life Insurance Company Ltd?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Net Income has been 21%. The projected CAGR for the next 3 years is 0%.
